Cargando…

A Continuous Renal Replacement Therapy Protocol for Patients with Acute Kidney Injury in Intensive Care Unit with COVID-19

COVID-19 often leads to acute respiratory distress syndrome complicated by acute kidney injury (AKI). The indications for renal replacement therapy for these patients are those commonly accepted to treat AKI. We describe a continuous veno-venous haemodialysis (CVVHD) protocol for AKI, which aims to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalesso, Federico, Garzotto, Francesco, Cattarin, Leda, Gobbi, Laura, Qassim, Laila, Sgarabotto, Luca, Tiberio, Ivo, Calò, Lorenzo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291081/ https://www.ncbi.nlm.nih.gov/pubmed/32438617 http://dx.doi.org/10.3390/jcm9051529

Ejemplares similares

Evaluating Nephrocheck(®) as a Predictive Tool for Acute Kidney Injury
por: Nalesso, Federico, et al.
Publicado: (2020)

The Supporting Role of Combined and Sequential Extracorporeal Blood Purification Therapies in COVID-19 Patients in Intensive Care Unit
por: Nalesso, Federico, et al.
Publicado: (2022)

Slow Continuous Ultrafiltration in Regional Citrate Anticoagulation Performed with a Standard Fluid Infusion Central Venous Catheter in Intensive Care Unit for Fluid Overload in Acute on Chronic Heart Failure: A Case Report
por: Nalesso, Federico, et al.
Publicado: (2023)

The patient safety in extracorporeal blood purification treatments of critical patients
por: Nalesso, Federico, et al.
Publicado: (2022)

Safety of Citrate Anticoagulation in CKRT: Monocentric Experience of a Dynamic Protocol of Calcium Monitoring
por: Nalesso, Federico, et al.
Publicado: (2023)

Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes
por: Sgarabotto, Luca, et al.
Publicado: (2023)

Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
por: Bertoldi, Giovanni, et al.
Publicado: (2021)

Preventing infectious diseases in Intensive Care Unit by medical devices remote control: Lessons from COVID-19
por: Garzotto, Francesco, et al.
Publicado: (2021)

Pathomechanism of oxidative stress in cardiovascular-renal remodeling and therapeutic strategies
por: Ravarotto, Verdiana, et al.
Publicado: (2022)

The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman’s and Bartter’s Syndromes
por: Francini, Francesco, et al.
Publicado: (2021)

High Blood Pressure Is Associated with Tubulointerstitial Damage along with Glomerular Damage in Glomerulonephritis. A large Cohort Study
por: Bazzi, Claudio, et al.
Publicado: (2020)

The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease
por: Ravarotto, Verdiana, et al.
Publicado: (2021)

Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit
por: Davenport, Andrew, et al.
Publicado: (2009)

Renal Replacement Therapy in Intensive Care Unit for Acute Kidney Injury
Publicado: (2020)

Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
por: Calò, Lorenzo A., et al.
Publicado: (2022)

Echocardiographic parameters of patients in the intensive care unit undergoing continuous renal replacement therapy
por: Kompotiatis, Panagiotis, et al.
Publicado: (2019)

Continuous Kidney Replacement Therapy Practices in Pediatric Intensive Care Units Across Europe
por: Daverio, Marco, et al.
Publicado: (2022)

Continuous renal replacement therapy for the treatment of acute kidney injury
por: Bae, Woo Kyun, et al.
Publicado: (2008)

Continuous renal replacement therapy in elderly with acute kidney injury
por: Medina-Liabres, Kristianne Rachel P., et al.
Publicado: (2020)

Continuous renal replacement therapy in elderly with acute kidney injury
por: Medina-Liabres, Kristianne Rachel P., et al.
Publicado: (2020)

Comparison of the Treatment Efficacy of Continuous Renal Replacement Therapy and Intermittent Hemodialysis in Patients With Acute Kidney İnjury Admitted to the Intensive Care Unit
por: Yılmaz Aydın, Fatma, et al.
Publicado: (2022)

Early initiation of renal replacement therapy in critically ill patients: a meta-analysis of randomized clinical trials
por: Pasin, Laura, et al.
Publicado: (2019)

Calcineurin-Inhibitor-Induced Hypomagnesemia in Kidney Transplant Patients: A Monocentric Comparative Study between Sucrosomial Magnesium and Magnesium Pidolate Supplementation
por: Stefanelli, Lucia Federica, et al.
Publicado: (2023)

Nomenclature for renal replacement therapy in acute kidney injury: basic principles
por: Neri, Mauro, et al.
Publicado: (2016)

Continuous renal replacement therapy in intensive care patients with COVID-19; survival and renal recovery
por: Eriksson, Karin E., et al.
Publicado: (2021)

Renal replacement therapy in the intensive care unit
por: Pannu, Neesh, et al.
Publicado: (2005)

Renal replacement therapy in the intensive care unit
por: Chacko, Jose
Publicado: (2008)

Pharmacokinetics of meropenem in intensive care patients receiving continuous renal replacement therapy
por: Giles, LJ, et al.
Publicado: (1998)

The lower limit of intensity to control uremia during continuous renal replacement therapy
por: Yasuda, Hideto, et al.
Publicado: (2014)

COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection
por: Calò, Lorenzo A., et al.
Publicado: (2022)

The influence of hypophosphatemia on outcomes of low- and high-intensity continuous renal replacement therapy in critically ill patients with acute kidney injury
por: Kim, Soo Young, et al.
Publicado: (2017)

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)
por: Ichai, Carole, et al.
Publicado: (2016)

Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More
por: Ravarotto, Verdiana, et al.
Publicado: (2022)

Dosing patterns for continuous renal replacement therapy in the United States
por: Venkataraman, R, et al.
Publicado: (2001)

Change in alkaline phosphatase activity associated with intensive care unit and hospital length of stay in patients with septic acute kidney injury on continuous renal replacement therapy
por: Baek, Seung Don, et al.
Publicado: (2018)

Incidence of acute kidney injury and use of renal replacement therapy in intensive care unit patients in Indonesia
por: Jonny, Jonny, et al.
Publicado: (2020)

ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes
por: Calò, Lorenzo A., et al.
Publicado: (2021)

The Assessment of Renal Functional Reserve in β-Thalassemia Major Patients by an Innovative Ultrasound and Doppler Technique: A Pilot Study
por: Nalesso, Federico, et al.
Publicado: (2022)

Clinical review: Timing and dose of continuous renal replacement therapy in acute kidney injury
por: Palevsky, Paul M
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_tqsebc241o72updvl5drgfbkj8